Skip to main content
Top
Published in:

16-01-2024 | Climate Change

One Health Approach to Addressing Fungal Infection Disparities

Authors: Mallika Sengupta, Aditya Kundu, Gayatree Nayak, Sonakshi Srivastava, Sayantan Banerjee

Published in: Current Fungal Infection Reports | Issue 1/2024

Login to get access

Abstract

Purpose of Review

Notable disparities can be observed in the distribution of fungal infections across different geographical and climatic regions, comorbidities, socioeconomic classes, and occupations of the human host. Significant differences also exist in the availability, affordability, and accessibility of diagnostic services and therapeutic choices against serious fungal infections across the globe. With the growth of the menace of antimicrobial resistance and the increase in number of patients susceptible to life-threatening fungal infections, there is an urgent need among clinicians, researchers, entrepreneurs, and policymakers to understand these disparities and address them adequately.

Recent Findings

Erstwhile known endemic fungal pathogens have recently been identified from newer geographical locations because of climate changes, human activities, and improved consciousness and diagnostics. Emerging fungal pathogens like the intercontinental spread of highly resistant Candida auris, resistance in Aspergillus and other hyaline molds due to overuse of newer antifungals in agriculture, COVID-associated mucormycosis, and natural disaster-associated invasive fungal infections have highlighted the importance of comprehensively addressing human fungal diseases from a One Health perspective.

Summary

This article aims to provide an understanding of the global multifactorial disparities in the distribution, diagnosis, and therapy of fungal infections and suggest different ways to address them through collaborative One Health approaches.
Literature
2.
3.
go back to reference Benedict K, Jackson BR, Chiller T, Beer KD. Estimation of direct healthcare costs of fungal diseases in the United States. Clin Infect Dis Off Publ Infect Dis Soc Am. 2019;68(11):1791–7.CrossRef Benedict K, Jackson BR, Chiller T, Beer KD. Estimation of direct healthcare costs of fungal diseases in the United States. Clin Infect Dis Off Publ Infect Dis Soc Am. 2019;68(11):1791–7.CrossRef
5.
7.
go back to reference Salzer HJF, Burchard G, Cornely OA, Lange C, Rolling T, Schmiedel S, et al. Diagnosis and management of systemic endemic mycoses causing pulmonary disease. Respir Int Rev Thorac Dis. 2018;96(3):283–301. Salzer HJF, Burchard G, Cornely OA, Lange C, Rolling T, Schmiedel S, et al. Diagnosis and management of systemic endemic mycoses causing pulmonary disease. Respir Int Rev Thorac Dis. 2018;96(3):283–301.
8.
go back to reference Baddley JW, Winthrop KL, Patkar NM, Delzell E, Beukelman T, Xie F, et al. Geographic distribution of endemic fungal infections among older persons. United States Emerg Infect Dis. 2011;17(9):1664–9.PubMedCrossRef Baddley JW, Winthrop KL, Patkar NM, Delzell E, Beukelman T, Xie F, et al. Geographic distribution of endemic fungal infections among older persons. United States Emerg Infect Dis. 2011;17(9):1664–9.PubMedCrossRef
9.
go back to reference Armstrong PA, Jackson BR, Haselow D, Fields V, Ireland M, Austin C, et al. Multistate epidemiology of histoplasmosis, United States, 2011–2014. Emerg Infect Dis. 2018;24(3):425–31.PubMedPubMedCentralCrossRef Armstrong PA, Jackson BR, Haselow D, Fields V, Ireland M, Austin C, et al. Multistate epidemiology of histoplasmosis, United States, 2011–2014. Emerg Infect Dis. 2018;24(3):425–31.PubMedPubMedCentralCrossRef
10.
go back to reference Farina C, Rizzi M, Ricci L, Gabbi E, Caligaris S, Goglio A. Imported and autochthonous histoplasmosis in Italy: new cases and old problems. Rev Iberoam Micol. 2005;22(03):169–71.PubMedCrossRef Farina C, Rizzi M, Ricci L, Gabbi E, Caligaris S, Goglio A. Imported and autochthonous histoplasmosis in Italy: new cases and old problems. Rev Iberoam Micol. 2005;22(03):169–71.PubMedCrossRef
11.
go back to reference Antinori S, Magni C, Nebuloni M, Parravicini C, Corbellino M, Sollima S, et al. Histoplasmosis among human immunodeficiency virus-infected people in Europe: report of 4 cases and review of the literature. Medicine (Baltimore). 2006;85(1):22–36.PubMedCrossRef Antinori S, Magni C, Nebuloni M, Parravicini C, Corbellino M, Sollima S, et al. Histoplasmosis among human immunodeficiency virus-infected people in Europe: report of 4 cases and review of the literature. Medicine (Baltimore). 2006;85(1):22–36.PubMedCrossRef
12.
13.
go back to reference Carvalho C, Ferreira I, Gaião S, Guimarães S, Costa R, Santos J, et al. Cerebral coccidioidomycosis after renal transplantation in a non-endemic area. Transpl Infect Dis. 2010;12(2):151–4.PubMedCrossRef Carvalho C, Ferreira I, Gaião S, Guimarães S, Costa R, Santos J, et al. Cerebral coccidioidomycosis after renal transplantation in a non-endemic area. Transpl Infect Dis. 2010;12(2):151–4.PubMedCrossRef
14.
go back to reference Simões LB, Marques SA, Bagagli E. Distribution of paracoccidioidomycosis: determination of ecologic correlates through spatial analyses. Med Mycol. 2004;42(6):517–23.PubMedCrossRef Simões LB, Marques SA, Bagagli E. Distribution of paracoccidioidomycosis: determination of ecologic correlates through spatial analyses. Med Mycol. 2004;42(6):517–23.PubMedCrossRef
16.
go back to reference Bonifaz A, Vázquez-González D, Perusquía-Ortiz AM. Endemic systemic mycoses: coccidioidomycosis, histoplasmosis, paracoccidioidomycosis and blastomycosis. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2011;9(9):705–14 (quiz 715). Bonifaz A, Vázquez-González D, Perusquía-Ortiz AM. Endemic systemic mycoses: coccidioidomycosis, histoplasmosis, paracoccidioidomycosis and blastomycosis. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2011;9(9):705–14 (quiz 715).
17.
go back to reference Seitz AE, Adjemian J, Steiner CA, Prevots DR. Spatial epidemiology of blastomycosis hospitalizations: detecting clusters and identifying environmental risk factors. Med Mycol. 2015;53(5):447–54.PubMedCrossRef Seitz AE, Adjemian J, Steiner CA, Prevots DR. Spatial epidemiology of blastomycosis hospitalizations: detecting clusters and identifying environmental risk factors. Med Mycol. 2015;53(5):447–54.PubMedCrossRef
19.
go back to reference Schwartz IS, Govender NP, Sigler L, Jiang Y, Maphanga TG, Toplis B, et al. Emergomyces: the global rise of new dimorphic fungal pathogens. PLoS Pathog. 2019;15(9):e1007977.PubMedPubMedCentralCrossRef Schwartz IS, Govender NP, Sigler L, Jiang Y, Maphanga TG, Toplis B, et al. Emergomyces: the global rise of new dimorphic fungal pathogens. PLoS Pathog. 2019;15(9):e1007977.PubMedPubMedCentralCrossRef
23.
go back to reference Head JR, Sondermeyer-Cooksey G, Heaney AK, Yu AT, Jones I, Bhattachan A, et al. Effects of precipitation, heat, and drought on incidence and expansion of coccidioidomycosis in western USA: a longitudinal surveillance study. Lancet Planet Health. 2022;6(10):e793-803.PubMedPubMedCentralCrossRef Head JR, Sondermeyer-Cooksey G, Heaney AK, Yu AT, Jones I, Bhattachan A, et al. Effects of precipitation, heat, and drought on incidence and expansion of coccidioidomycosis in western USA: a longitudinal surveillance study. Lancet Planet Health. 2022;6(10):e793-803.PubMedPubMedCentralCrossRef
27.
go back to reference Egger NB, Kainz K, Schulze A, Bauer MA, Madeo F, Carmona-Gutierrez D. The rise of Candida auris: from unique traits to co-infection potential. Microb Cell. 2022;9(8):141–4.PubMedPubMedCentralCrossRef Egger NB, Kainz K, Schulze A, Bauer MA, Madeo F, Carmona-Gutierrez D. The rise of Candida auris: from unique traits to co-infection potential. Microb Cell. 2022;9(8):141–4.PubMedPubMedCentralCrossRef
29.
go back to reference Slavin MA, Chakrabarti A. Opportunistic fungal infections in the Asia-Pacific region. Med Mycol. 2012;50(1):18–25.PubMedCrossRef Slavin MA, Chakrabarti A. Opportunistic fungal infections in the Asia-Pacific region. Med Mycol. 2012;50(1):18–25.PubMedCrossRef
30.
go back to reference Neblett Fanfair R, Benedict K, Bos J, Bennett SD, Lo YC, Adebanjo T, et al. Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med. 2012;367(23):2214–25.PubMedCrossRef Neblett Fanfair R, Benedict K, Bos J, Bennett SD, Lo YC, Adebanjo T, et al. Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med. 2012;367(23):2214–25.PubMedCrossRef
32.
go back to reference Mansoor S, Ahmed TI, Happa K, Sultan M, Manhas S, Shamas S. Spectrum of mucormycosis before and during COVID-19: epidemiology, diagnosis, and current therapeutic interventions. Curr Fungal Infect Rep. 2022;16(4):131–42.PubMedPubMedCentralCrossRef Mansoor S, Ahmed TI, Happa K, Sultan M, Manhas S, Shamas S. Spectrum of mucormycosis before and during COVID-19: epidemiology, diagnosis, and current therapeutic interventions. Curr Fungal Infect Rep. 2022;16(4):131–42.PubMedPubMedCentralCrossRef
34.
go back to reference Al-Tawfiq JA, Boukhamseen A. Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei (formerly Ramichloridium mackenziei): case presentation and literature review. J Infect Public Health. 2011;4(2):96–102.PubMedCrossRef Al-Tawfiq JA, Boukhamseen A. Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei (formerly Ramichloridium mackenziei): case presentation and literature review. J Infect Public Health. 2011;4(2):96–102.PubMedCrossRef
35.
go back to reference Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4(165):165rv13.PubMedCrossRef Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4(165):165rv13.PubMedCrossRef
36.
go back to reference Puel A, Cypowyj S, Maródi L, Abel L, Picard C, Casanova JL. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol. 2012;12(6):616–22.PubMedPubMedCentralCrossRef Puel A, Cypowyj S, Maródi L, Abel L, Picard C, Casanova JL. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol. 2012;12(6):616–22.PubMedPubMedCentralCrossRef
37.
go back to reference Smeekens SP, Ng A, Kumar V, Johnson MD, Plantinga TS, van Diemen C, et al. Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans. Nat Commun. 2013;4:1342.ADSPubMedCrossRef Smeekens SP, Ng A, Kumar V, Johnson MD, Plantinga TS, van Diemen C, et al. Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans. Nat Commun. 2013;4:1342.ADSPubMedCrossRef
39.
go back to reference Pfaller MA, Carvalhaes CG, DeVries S, Huband MD, Castanheira M. Elderly versus nonelderly patients with invasive fungal infections: species distribution and antifungal resistance, SENTRY antifungal surveillance program 2017–2019. Diagn Microbiol Infect Dis. 2022;102(4):115627.PubMedCrossRef Pfaller MA, Carvalhaes CG, DeVries S, Huband MD, Castanheira M. Elderly versus nonelderly patients with invasive fungal infections: species distribution and antifungal resistance, SENTRY antifungal surveillance program 2017–2019. Diagn Microbiol Infect Dis. 2022;102(4):115627.PubMedCrossRef
40.
41.
go back to reference Pourbaix A, Lafont Rapnouil B, Guéry R, Lanternier F, Lortholary O, Cohen JF. Smoking as a risk factor of invasive fungal disease: systematic review and meta-analysis. Clin Infect Dis. 2020;71(4):1106–19.PubMedCrossRef Pourbaix A, Lafont Rapnouil B, Guéry R, Lanternier F, Lortholary O, Cohen JF. Smoking as a risk factor of invasive fungal disease: systematic review and meta-analysis. Clin Infect Dis. 2020;71(4):1106–19.PubMedCrossRef
42.
go back to reference Soysa NS, Ellepola ANB. The impact of cigarette/tobacco smoking on oral candidosis: an overview. Oral Dis. 2005;11(5):268–73.PubMedCrossRef Soysa NS, Ellepola ANB. The impact of cigarette/tobacco smoking on oral candidosis: an overview. Oral Dis. 2005;11(5):268–73.PubMedCrossRef
44.
go back to reference Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi Basel Switz. 2017;3(4):57.CrossRef Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi Basel Switz. 2017;3(4):57.CrossRef
45.
go back to reference Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis Off Publ Infect Dis Soc Am. 2010;50(8):1101–11.CrossRef Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis Off Publ Infect Dis Soc Am. 2010;50(8):1101–11.CrossRef
47.
go back to reference Pagano L, Caira M, Nosari A, Van Lint MT, Candoni A, Offidani M, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study–sorveglianza epidemiologica infezioni fungine nelle emopatie maligne. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007;45(9):1161–70.CrossRef Pagano L, Caira M, Nosari A, Van Lint MT, Candoni A, Offidani M, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study–sorveglianza epidemiologica infezioni fungine nelle emopatie maligne. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007;45(9):1161–70.CrossRef
48.
go back to reference Singh N, Huprikar S, Burdette SD, Morris MI, Blair JE, Wheat LJ, et al. Donor-derived fungal infections in organ transplant recipients: guidelines of the American Society of Transplantation, infectious diseases community of practice. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2012;12(9):2414–28.CrossRef Singh N, Huprikar S, Burdette SD, Morris MI, Blair JE, Wheat LJ, et al. Donor-derived fungal infections in organ transplant recipients: guidelines of the American Society of Transplantation, infectious diseases community of practice. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2012;12(9):2414–28.CrossRef
49.
go back to reference Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J. 2016;47(1):45–68.PubMedCrossRef Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J. 2016;47(1):45–68.PubMedCrossRef
50.
go back to reference Gothe F, Schmautz A, Häusler K, Tran NB, Kappler M, Griese M. Treating allergic bronchopulmonary aspergillosis with short-term prednisone and itraconazole in cystic fibrosis. J Allergy Clin Immunol Pract. 2020;8(8):2608-2614.e3.PubMedCrossRef Gothe F, Schmautz A, Häusler K, Tran NB, Kappler M, Griese M. Treating allergic bronchopulmonary aspergillosis with short-term prednisone and itraconazole in cystic fibrosis. J Allergy Clin Immunol Pract. 2020;8(8):2608-2614.e3.PubMedCrossRef
52.
go back to reference Bitar D, Lortholary O, Le Strat Y, Nicolau J, Coignard B, Tattevin P, et al. Population-based analysis of invasive fungal infections, France, 2001–2010. Emerg Infect Dis. 2014;20(7):1149–55.PubMedPubMedCentralCrossRef Bitar D, Lortholary O, Le Strat Y, Nicolau J, Coignard B, Tattevin P, et al. Population-based analysis of invasive fungal infections, France, 2001–2010. Emerg Infect Dis. 2014;20(7):1149–55.PubMedPubMedCentralCrossRef
53.
54.
go back to reference Birhanu MY, Temesgen H, Ketema DB, Desta M, Getaneh T, Bekele GM, et al. Tinea capitis among schoolchildren in Ethiopia: a systematic review and meta analysis. PLoS One. 2023;18(2):0280948.CrossRef Birhanu MY, Temesgen H, Ketema DB, Desta M, Getaneh T, Bekele GM, et al. Tinea capitis among schoolchildren in Ethiopia: a systematic review and meta analysis. PLoS One. 2023;18(2):0280948.CrossRef
55.
go back to reference Chander J, Kaur M, Singla N, Punia RPS, Singhal SK, Attri AK, et al. Mucormycosis: battle with the deadly enemy over a five-year period in India. J Fungi. 2018;4(2):46.CrossRef Chander J, Kaur M, Singla N, Punia RPS, Singhal SK, Attri AK, et al. Mucormycosis: battle with the deadly enemy over a five-year period in India. J Fungi. 2018;4(2):46.CrossRef
57.
go back to reference Gangneux JP, Adjidé CC, Bernard L, Botterel F, Carel A, Castel O, et al. Quantitative assessment of fungal risk in the case of construction works in healthcare establishments: proposed indicators for the determination of the impact of management precautions on the risk of fungal infection. J Mycol Medicale. 2012;22(1):64–71.CrossRef Gangneux JP, Adjidé CC, Bernard L, Botterel F, Carel A, Castel O, et al. Quantitative assessment of fungal risk in the case of construction works in healthcare establishments: proposed indicators for the determination of the impact of management precautions on the risk of fungal infection. J Mycol Medicale. 2012;22(1):64–71.CrossRef
58.
go back to reference Freedman M, Jackson BR, McCotter O, Benedict K. Coccidioidomycosis outbreaks, United States and worldwide, 1940–2015. Emerg Infect Dis. 2018;24(3):417–24.PubMedPubMedCentralCrossRef Freedman M, Jackson BR, McCotter O, Benedict K. Coccidioidomycosis outbreaks, United States and worldwide, 1940–2015. Emerg Infect Dis. 2018;24(3):417–24.PubMedPubMedCentralCrossRef
60.
go back to reference Malik A, Ali S, Shahid M, Bhargava R. Occupational exposure to Aspergillus and aflatoxins among food-grain workers in India. Int J Occup Environ Health. 2014;20(3):189–93.PubMedPubMedCentralCrossRef Malik A, Ali S, Shahid M, Bhargava R. Occupational exposure to Aspergillus and aflatoxins among food-grain workers in India. Int J Occup Environ Health. 2014;20(3):189–93.PubMedPubMedCentralCrossRef
61.
go back to reference Lin Y, Zhang J, Han X, Hu J. A retrospective study of the spectrum of fungal keratitis in southeastern China. Ann Palliat Med. 2021;10(9):9480487–9487.CrossRef Lin Y, Zhang J, Han X, Hu J. A retrospective study of the spectrum of fungal keratitis in southeastern China. Ann Palliat Med. 2021;10(9):9480487–9487.CrossRef
63.
go back to reference Hajjeh R, McDonnell S, Reef S, Licitra C, Hankins M, Toth B, et al. Outbreak of sporotrichosis among tree nursery workers. J Infect Dis. 1997;176(2):499–504.PubMedCrossRef Hajjeh R, McDonnell S, Reef S, Licitra C, Hankins M, Toth B, et al. Outbreak of sporotrichosis among tree nursery workers. J Infect Dis. 1997;176(2):499–504.PubMedCrossRef
65.
go back to reference Zhang Y, Hagen F, Stielow B, Rodrigues AM, Samerpitak K, Zhou X, et al. Phylogeography and evolutionary patterns in Sporothrix spanning more than 14 000 human and animal case reports. Persoonia - Mol Phylogeny Evol Fungi. 2015;35(1):1–20.CrossRef Zhang Y, Hagen F, Stielow B, Rodrigues AM, Samerpitak K, Zhou X, et al. Phylogeography and evolutionary patterns in Sporothrix spanning more than 14 000 human and animal case reports. Persoonia - Mol Phylogeny Evol Fungi. 2015;35(1):1–20.CrossRef
66.
go back to reference Rossow JA, Queiroz-Telles F, Caceres DH, Beer KD, Jackson BR, Pereira JG, et al. A One Health approach to combatting Sporothrix brasiliensis: narrative review of an emerging zoonotic fungal pathogen in South America. J Fungi Basel Switz. 2020;6(4):247.CrossRef Rossow JA, Queiroz-Telles F, Caceres DH, Beer KD, Jackson BR, Pereira JG, et al. A One Health approach to combatting Sporothrix brasiliensis: narrative review of an emerging zoonotic fungal pathogen in South America. J Fungi Basel Switz. 2020;6(4):247.CrossRef
67.
go back to reference do Monte Alves M, Milan EP, da Silva-Rocha WP, de Sena da Costa AS, Maciel BA, Vale PHC, et al. Fatal pulmonary sporotrichosis caused by Sporothrix brasiliensis in Northeast Brazil. PLoS Negl Trop Dis. 2020;14(5):e0008141.PubMedPubMedCentralCrossRef do Monte Alves M, Milan EP, da Silva-Rocha WP, de Sena da Costa AS, Maciel BA, Vale PHC, et al. Fatal pulmonary sporotrichosis caused by Sporothrix brasiliensis in Northeast Brazil. PLoS Negl Trop Dis. 2020;14(5):e0008141.PubMedPubMedCentralCrossRef
68.
go back to reference de Perio MA, Benedict K, Williams SL, Niemeier-Walsh C, Green BJ, Coffey C, et al. Occupational histoplasmosis: epidemiology and prevention measures. J Fungi. 2021;7(7):510.CrossRef de Perio MA, Benedict K, Williams SL, Niemeier-Walsh C, Green BJ, Coffey C, et al. Occupational histoplasmosis: epidemiology and prevention measures. J Fungi. 2021;7(7):510.CrossRef
69.
go back to reference Chowdhary A, Sharma C, Meis JF. Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLOS Pathog. 2017;13(5):e1006290.PubMedPubMedCentralCrossRef Chowdhary A, Sharma C, Meis JF. Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLOS Pathog. 2017;13(5):e1006290.PubMedPubMedCentralCrossRef
70.
go back to reference Keri VC, Kumar A, Singh G, Xess I, Khan MA, Rastogi N, et al. Fungal carriage on healthcare workers’ hands, clothing, stethoscopes and electronic devices during routine patient care: a study from a tertiary care center. J Prev Med Hyg. 2021;62(1):E170–3.PubMedPubMedCentral Keri VC, Kumar A, Singh G, Xess I, Khan MA, Rastogi N, et al. Fungal carriage on healthcare workers’ hands, clothing, stethoscopes and electronic devices during routine patient care: a study from a tertiary care center. J Prev Med Hyg. 2021;62(1):E170–3.PubMedPubMedCentral
73.
go back to reference Assress HA, Selvarajan R, Nyoni H, Ogola HJO, Mamba BB, Msagati TAM. Azole antifungal resistance in fungal isolates from wastewater treatment plant effluents. Environ Sci Pollut Res Int. 2021;28(3):3217–29.PubMedCrossRef Assress HA, Selvarajan R, Nyoni H, Ogola HJO, Mamba BB, Msagati TAM. Azole antifungal resistance in fungal isolates from wastewater treatment plant effluents. Environ Sci Pollut Res Int. 2021;28(3):3217–29.PubMedCrossRef
74.
go back to reference Snelders E, Karawajczyk A, Schaftenaar G, Verweij PE, Melchers WJG. Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling. Antimicrob Agents Chemother. 2010;54(6):2425–30.PubMedPubMedCentralCrossRef Snelders E, Karawajczyk A, Schaftenaar G, Verweij PE, Melchers WJG. Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling. Antimicrob Agents Chemother. 2010;54(6):2425–30.PubMedPubMedCentralCrossRef
76.
go back to reference Chowdhary A, Prakash A, Sharma C, Kordalewska M, Kumar A, Sarma S, et al. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. J Antimicrob Chemother. 2018;73(4):891–9.PubMedCrossRef Chowdhary A, Prakash A, Sharma C, Kordalewska M, Kumar A, Sarma S, et al. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. J Antimicrob Chemother. 2018;73(4):891–9.PubMedCrossRef
77.
go back to reference Ben-Ami R, Berman J, Novikov A, Bash E, Shachor-Meyouhas Y, Zakin S, et al. Multidrug-resistant Candida haemulonii and C. auris, Tel Aviv. Israel Emerg Infect Dis. 2017;23:195–203.PubMed Ben-Ami R, Berman J, Novikov A, Bash E, Shachor-Meyouhas Y, Zakin S, et al. Multidrug-resistant Candida haemulonii and C. auris, Tel Aviv. Israel Emerg Infect Dis. 2017;23:195–203.PubMed
78.
go back to reference Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN. Twenty years of the SENTRY antifungal surveillance program: results for Candida species From 1997–2016. Open Forum Infect Dis. 2019;6(Suppl 1):S79-94.PubMedPubMedCentralCrossRef Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN. Twenty years of the SENTRY antifungal surveillance program: results for Candida species From 1997–2016. Open Forum Infect Dis. 2019;6(Suppl 1):S79-94.PubMedPubMedCentralCrossRef
79.
go back to reference Kushima H, Tokimatsu I, Ishii H, Kadota J-I. Antifungal susceptibility and drug-resistant mechanism of Trichosporon. Med Mycol J. 2015;56(4):J123-128.PubMedCrossRef Kushima H, Tokimatsu I, Ishii H, Kadota J-I. Antifungal susceptibility and drug-resistant mechanism of Trichosporon. Med Mycol J. 2015;56(4):J123-128.PubMedCrossRef
80.
81.
go back to reference Sacheli R, Hayette MP. Antifungal resistance in dermatophytes: genetic considerations, clinical presentations and alternative therapies. J Fungi. 2021;7(11):983.CrossRef Sacheli R, Hayette MP. Antifungal resistance in dermatophytes: genetic considerations, clinical presentations and alternative therapies. J Fungi. 2021;7(11):983.CrossRef
82.
go back to reference Pashootan N, Shams-Ghahfarokhi M, Nusrati AC, Salehi Z, Asmar M, Razzaghi-Abyaneh M. Antifungal susceptibility, and point mutations of SQLE gene in major pathogenic dermatophytes isolated from clinical dermatophytosis. Front Cell Infect Microbiol. 2022;12:851769.PubMedPubMedCentralCrossRef Pashootan N, Shams-Ghahfarokhi M, Nusrati AC, Salehi Z, Asmar M, Razzaghi-Abyaneh M. Antifungal susceptibility, and point mutations of SQLE gene in major pathogenic dermatophytes isolated from clinical dermatophytosis. Front Cell Infect Microbiol. 2022;12:851769.PubMedPubMedCentralCrossRef
83.
go back to reference Fisher MC, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell EM, Bowyer P, et al. Tackling the emerging threat of antifungal resistance to human health. Nat Rev Microbiol. 2022;20(9):557–71.PubMedPubMedCentralCrossRef Fisher MC, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell EM, Bowyer P, et al. Tackling the emerging threat of antifungal resistance to human health. Nat Rev Microbiol. 2022;20(9):557–71.PubMedPubMedCentralCrossRef
84.
go back to reference • Fang W, Wu J, Cheng M, Zhu X, Du M, Chen C, et al. Diagnosis of invasive fungal infections: challenges and recent developments. J Biomed Sci. 2023;30(1):42. (It discusses the advances in molecular methods, advances in serology-based methods, advances in biosensor technology, and advances in machine learning-based models.)PubMedPubMedCentralCrossRef • Fang W, Wu J, Cheng M, Zhu X, Du M, Chen C, et al. Diagnosis of invasive fungal infections: challenges and recent developments. J Biomed Sci. 2023;30(1):42. (It discusses the advances in molecular methods, advances in serology-based methods, advances in biosensor technology, and advances in machine learning-based models.)PubMedPubMedCentralCrossRef
85.
go back to reference Chindamporn A, Chakrabarti A, Li R, Sun PL, Tan BH, Chua M, et al. Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: an Asia Fungal Working Group (AFWG) initiative. Med Mycol. 2018;56(4):416–25.PubMedCrossRef Chindamporn A, Chakrabarti A, Li R, Sun PL, Tan BH, Chua M, et al. Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: an Asia Fungal Working Group (AFWG) initiative. Med Mycol. 2018;56(4):416–25.PubMedCrossRef
86.
go back to reference Prasad P, Fishman JA. Impact and cost of the serum galactomannan assay at a tertiary care facility. Transplantation. 2014;98(7):773–80.PubMedCrossRef Prasad P, Fishman JA. Impact and cost of the serum galactomannan assay at a tertiary care facility. Transplantation. 2014;98(7):773–80.PubMedCrossRef
87.
go back to reference Pfaller MA, Wolk DM, Lowery TJ. T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis. Future Microbiol. 2016;11(1):103–17.PubMedCrossRef Pfaller MA, Wolk DM, Lowery TJ. T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis. Future Microbiol. 2016;11(1):103–17.PubMedCrossRef
88.
go back to reference Lakoh S, Kamudumuli PS, Penney ROS, Haumba SM, Jarvis JN, Hassan AJ, et al. Diagnostic capacity for invasive fungal infections in advanced HIV disease in Africa: a continent-wide survey. Lancet Infect Dis. 2023;23(5):598–608.PubMedCrossRef Lakoh S, Kamudumuli PS, Penney ROS, Haumba SM, Jarvis JN, Hassan AJ, et al. Diagnostic capacity for invasive fungal infections in advanced HIV disease in Africa: a continent-wide survey. Lancet Infect Dis. 2023;23(5):598–608.PubMedCrossRef
90.
go back to reference Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019;19(12):e405–21.PubMedPubMedCentralCrossRef Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019;19(12):e405–21.PubMedPubMedCentralCrossRef
92.
go back to reference Milani B, Dagne DA, Choi HL, Schito M, Stone HA. Diagnostic capacities and treatment practices on implantation mycoses: results from the 2022 WHO global online survey. PLoS Negl Trop Dis. 2023;17(6):e0011443.PubMedPubMedCentralCrossRef Milani B, Dagne DA, Choi HL, Schito M, Stone HA. Diagnostic capacities and treatment practices on implantation mycoses: results from the 2022 WHO global online survey. PLoS Negl Trop Dis. 2023;17(6):e0011443.PubMedPubMedCentralCrossRef
93.
go back to reference Kneale M, Bartholomew JS, Davies E, Denning DW. Global access to antifungal therapy and its variable cost. J Antimicrob Chemother. 2016;71(12):3599–606.PubMedCrossRef Kneale M, Bartholomew JS, Davies E, Denning DW. Global access to antifungal therapy and its variable cost. J Antimicrob Chemother. 2016;71(12):3599–606.PubMedCrossRef
94.
go back to reference • Pathadka S, Yan VKC, Neoh CF, Al-Badriyeh D, Kong DCM, Slavin MA, et al. Global consumption trend of antifungal agents in humans from 2008 to 2018: data from 65 middle- and high-income countries. Drugs. 2022;82(11):1193–205. (Global consumption of triazoles and terbinafine has gradually increased in middle- and high-income countries. Life-saving antifungal agents, including echinocandins and polyenes, are available only parenterally and may be underutilized, mainly in middle-income countries.)PubMedPubMedCentralCrossRef • Pathadka S, Yan VKC, Neoh CF, Al-Badriyeh D, Kong DCM, Slavin MA, et al. Global consumption trend of antifungal agents in humans from 2008 to 2018: data from 65 middle- and high-income countries. Drugs. 2022;82(11):1193–205. (Global consumption of triazoles and terbinafine has gradually increased in middle- and high-income countries. Life-saving antifungal agents, including echinocandins and polyenes, are available only parenterally and may be underutilized, mainly in middle-income countries.)PubMedPubMedCentralCrossRef
95.
go back to reference Denning DW, Page ID, Chakaya J, Jabeen K, Jude CM, Cornet M, et al. Case definition of chronic pulmonary aspergillosis in resource-constrained settings. Emerg Infect Dis. 2018;24(8):e171312.PubMedPubMedCentralCrossRef Denning DW, Page ID, Chakaya J, Jabeen K, Jude CM, Cornet M, et al. Case definition of chronic pulmonary aspergillosis in resource-constrained settings. Emerg Infect Dis. 2018;24(8):e171312.PubMedPubMedCentralCrossRef
96.
go back to reference Ou HT, Lee TY, Chen YC, Charbonneau C. Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species. BMC Infect Dis. 2017;17(1):481.PubMedPubMedCentralCrossRef Ou HT, Lee TY, Chen YC, Charbonneau C. Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species. BMC Infect Dis. 2017;17(1):481.PubMedPubMedCentralCrossRef
97.
go back to reference Neoh C, Slavin M, Chen S, Stewart K, Kong D. Echinocandins in the treatment of candidaemia and invasive candidiasis: clinical and economic perspectives. Int J Antimicrob Agents. 2014;1(43):207–14.CrossRef Neoh C, Slavin M, Chen S, Stewart K, Kong D. Echinocandins in the treatment of candidaemia and invasive candidiasis: clinical and economic perspectives. Int J Antimicrob Agents. 2014;1(43):207–14.CrossRef
98.
go back to reference Lawrence DS, Muthoga C, Meya DB, Tugume L, Williams D, Rajasingham R, et al. Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial. Lancet Glob Health. 2022;10(12):e1845–54.PubMedPubMedCentralCrossRef Lawrence DS, Muthoga C, Meya DB, Tugume L, Williams D, Rajasingham R, et al. Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial. Lancet Glob Health. 2022;10(12):e1845–54.PubMedPubMedCentralCrossRef
99.
go back to reference Loyse A, Thangaraj H, Easterbrook P, Ford N, Roy M, Chiller T, et al. Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries. Lancet Infect Dis. 2013;13(7):629–37.PubMedCrossRef Loyse A, Thangaraj H, Easterbrook P, Ford N, Roy M, Chiller T, et al. Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries. Lancet Infect Dis. 2013;13(7):629–37.PubMedCrossRef
100.
go back to reference Bagshaw E, Kuessner D, Posthumus J, Escrig C, Blackney M, Heimann SM, et al. The cost of treating mucormycosis with isavuconazole compared with standard therapy in the UK. Future Microbiol. 2017;12(6):515–25.PubMedCrossRef Bagshaw E, Kuessner D, Posthumus J, Escrig C, Blackney M, Heimann SM, et al. The cost of treating mucormycosis with isavuconazole compared with standard therapy in the UK. Future Microbiol. 2017;12(6):515–25.PubMedCrossRef
104.
go back to reference Gopichandran V, Tirupakuzhi Vijayaraghavan BK. Coverage of antimicrobial resistance in the revised Indian medical curriculum: lip service only? Educ Health Abingdon Engl. 2020;33(2):70–3.CrossRef Gopichandran V, Tirupakuzhi Vijayaraghavan BK. Coverage of antimicrobial resistance in the revised Indian medical curriculum: lip service only? Educ Health Abingdon Engl. 2020;33(2):70–3.CrossRef
105.
go back to reference Cruz-Luna AR, Cruz-Martínez H, Vásquez-López A, Medina DI. Metal nanoparticles as novel antifungal agents for sustainable agriculture: current advances and future directions. J Fungi. 2021;7(12):1033.CrossRef Cruz-Luna AR, Cruz-Martínez H, Vásquez-López A, Medina DI. Metal nanoparticles as novel antifungal agents for sustainable agriculture: current advances and future directions. J Fungi. 2021;7(12):1033.CrossRef
106.
go back to reference Bastos RW, Rossato L, Goldman GH, Santos DA. Fungicide effects on human fungal pathogens: cross-resistance to medical drugs and beyond. PLoS Pathog. 2021;17(12):e1010073.PubMedPubMedCentralCrossRef Bastos RW, Rossato L, Goldman GH, Santos DA. Fungicide effects on human fungal pathogens: cross-resistance to medical drugs and beyond. PLoS Pathog. 2021;17(12):e1010073.PubMedPubMedCentralCrossRef
108.
go back to reference Chang CC, Athan E, Morrissey CO, Slavin MA. Preventing invasive fungal infection during hospital building works. Intern Med J. 2008;38(6b):538–41.PubMedCrossRef Chang CC, Athan E, Morrissey CO, Slavin MA. Preventing invasive fungal infection during hospital building works. Intern Med J. 2008;38(6b):538–41.PubMedCrossRef
112.
go back to reference Chang CC, Athan E, Morrissey CO, Slavin MA. Preventing invasive fungal infection during hospital building works. Intern Med J. 2008;38(6b):538–41.PubMedCrossRef Chang CC, Athan E, Morrissey CO, Slavin MA. Preventing invasive fungal infection during hospital building works. Intern Med J. 2008;38(6b):538–41.PubMedCrossRef
113.
go back to reference Gade L, McCotter OZ, Bowers JR, Waddell V, Brady S, Carvajal JA, et al. The detection of Coccidioides from ambient air in Phoenix, Arizona: evidence of uneven distribution and seasonality. Med Mycol. 2020;58(4):552–9.PubMedCrossRef Gade L, McCotter OZ, Bowers JR, Waddell V, Brady S, Carvajal JA, et al. The detection of Coccidioides from ambient air in Phoenix, Arizona: evidence of uneven distribution and seasonality. Med Mycol. 2020;58(4):552–9.PubMedCrossRef
114.
go back to reference Morris G, Kokki MH, Anderson K, Richardson MD. Sampling of Aspergillus spores in air. J Hosp Infect. 2000;44(2):81–92.PubMedCrossRef Morris G, Kokki MH, Anderson K, Richardson MD. Sampling of Aspergillus spores in air. J Hosp Infect. 2000;44(2):81–92.PubMedCrossRef
115.
go back to reference Park JH, Ryu SH, Lee JY, Kim HJ, Kwak SH, Jung J, et al. Airborne fungal spores and invasive aspergillosis in hematologic units in a tertiary hospital during construction: a prospective cohort study. Antimicrob Resist Infect Control. 2019;8(1):88.PubMedPubMedCentralCrossRef Park JH, Ryu SH, Lee JY, Kim HJ, Kwak SH, Jung J, et al. Airborne fungal spores and invasive aspergillosis in hematologic units in a tertiary hospital during construction: a prospective cohort study. Antimicrob Resist Infect Control. 2019;8(1):88.PubMedPubMedCentralCrossRef
116.
go back to reference Alegria W, Patel PK. The current state of antifungal stewardship in immunocompromised populations. J Fungi. 2021;7(5):352.CrossRef Alegria W, Patel PK. The current state of antifungal stewardship in immunocompromised populations. J Fungi. 2021;7(5):352.CrossRef
117.
go back to reference Johnson MD, Lewis RE, Dodds Ashley ES, Ostrosky-Zeichner L, Zaoutis T, Thompson GR III, et al. Core recommendations for antifungal stewardship: a statement of the mycoses study group education and research consortium. J Infect Dis. 2020;222(Supplement 3):S175-98.PubMedPubMedCentralCrossRef Johnson MD, Lewis RE, Dodds Ashley ES, Ostrosky-Zeichner L, Zaoutis T, Thompson GR III, et al. Core recommendations for antifungal stewardship: a statement of the mycoses study group education and research consortium. J Infect Dis. 2020;222(Supplement 3):S175-98.PubMedPubMedCentralCrossRef
118.
go back to reference Segal E, Elad D. Human and zoonotic dermatophytoses: epidemiological aspects. Front Microbiol. 2021;6(12):713532.CrossRef Segal E, Elad D. Human and zoonotic dermatophytoses: epidemiological aspects. Front Microbiol. 2021;6(12):713532.CrossRef
121.
go back to reference Gupta N, Potdar V, Praharaj I, Giri S, Sapkal G, Yadav P, et al. Laboratory preparedness for SARS-CoV-2 testing in India: harnessing a network of Virus Research & Diagnostic Laboratories. Indian J Med Res. 2020;151(2–3):216–25.PubMedPubMedCentral Gupta N, Potdar V, Praharaj I, Giri S, Sapkal G, Yadav P, et al. Laboratory preparedness for SARS-CoV-2 testing in India: harnessing a network of Virus Research & Diagnostic Laboratories. Indian J Med Res. 2020;151(2–3):216–25.PubMedPubMedCentral
123.
go back to reference Butler EK, Boulware DR, Bohjanen PR, Meya DB. Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda. PLoS One. 2012;7(12):e51291.ADSPubMedPubMedCentralCrossRef Butler EK, Boulware DR, Bohjanen PR, Meya DB. Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda. PLoS One. 2012;7(12):e51291.ADSPubMedPubMedCentralCrossRef
124.
go back to reference Hoenigl M, Sprute R, Egger M, Arastehfar A, Cornely OA, Krause R, et al. The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin. Drugs. 2021;81(15):1703–29.PubMedPubMedCentralCrossRef Hoenigl M, Sprute R, Egger M, Arastehfar A, Cornely OA, Krause R, et al. The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin. Drugs. 2021;81(15):1703–29.PubMedPubMedCentralCrossRef
125.
go back to reference Mehra T, Köberle M, Braunsdorf C, Mailänder-Sanchez D, Borelli C, Schaller M. Alternative approaches to antifungal therapies. Exp Dermatol. 2012;21(10):778–82.PubMedPubMedCentralCrossRef Mehra T, Köberle M, Braunsdorf C, Mailänder-Sanchez D, Borelli C, Schaller M. Alternative approaches to antifungal therapies. Exp Dermatol. 2012;21(10):778–82.PubMedPubMedCentralCrossRef
Metadata
Title
One Health Approach to Addressing Fungal Infection Disparities
Authors
Mallika Sengupta
Aditya Kundu
Gayatree Nayak
Sonakshi Srivastava
Sayantan Banerjee
Publication date
16-01-2024
Publisher
Springer US
Keyword
Climate Change
Published in
Current Fungal Infection Reports / Issue 1/2024
Print ISSN: 1936-3761
Electronic ISSN: 1936-377X
DOI
https://doi.org/10.1007/s12281-023-00480-2

Other articles of this Issue 1/2024

Current Fungal Infection Reports 1/2024 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare